Synopsis:
This prospective study highlights the utilization pattern and financial
burden of the paradigm of sedation, analgesia and neuromuscular
blockade in an intensive care unit. Cost for this treatment alone
accounts for more than 50% of the total drug cost in the intensive
care unit.